Hosted on MSN1mon
Novo Nordisk slashes U.S. list prices for insulin meds Tresiba, Fiasp
Tresiba (insulin degludec) and Fiasp (insulin aspart), by more than 70% starting Jan. 1, 2026. Fiasp's price will be reduced by 75%, making it the same price as NovoLog (insuin aspart), while ...
pharmaphorum5d
Novo Nordisk’s diabetes treatments approved in EU
The approval covers all 27 European Union member states. Tresiba (insulin degludec) is a once-daily new-generation based insulin analogue with an ultra-long duration of action. Ryzodeg (insulin ...
pharmaphorum6d
Novo cleared to add key data to Tresiba label
The FDA has ruled that Novo can include data from the Devote study on Tresiba’s (insulin degludec) label, which shows that it can reduce risk of hypoglycaemia by 40% compared with Sanofi’s ...
KAAL TV4d
Novo Nordisk insulin now $35 per month for Minnesotans thanks to Attorney General Keith Ellison
Attorney General Keith Ellison announced a settlement with Novo Nordisk that let's Minnesotans buy its insulin products for ...